News
The Role of Pharmacists in Opioid Addiction Management
The societal harm which happens to be brought on by the opioid epidemic happens to be incalculable. Because of their drug expertise as well as direct patient care, pharmacists are pretty critical when it comes to addressing crisis by...
Drug Research
Drug Wars Continue Despite Registry Patent Listing Crackdown
No company happened to be hit harder by the US Federal Trade Commission’s crackdown when it came to patents listed on the federal registry of approved drugs than Teva Pharmaceutical Industries Ltd., the Israeli drugmaker, and the fact that...
IT & Data Management
Clinical Trial Authority: Patient Retention Tech Revolution
Recent years have gone on to see a promising trend- the application of technology so as to revolutionize patient engagement as well as retention strategies. Right from mobile applications to electronic clinical outcome assessments- eCOA and Patient-Reported Outcome Measures-...
News
Health Complications Linked to Diabetes: What You Need to Know
Diabetes, a condition that currently affects millions around the world, is a pervasive health issue that can affect nearly every facet of an individual's well-being, from their heart to their nerves, eyes, and beyond.
This chronic condition, characterized by either...
News
FedEx Named Overall Logistics & Supply Chain Management Supplier of the Year at the Asia Pacific Biopharma Excellence Awards 2024
FedEx Express (FedEx), a subsidiary of FedEx Corp and one of the world’s largest express transportation companies, has been named ‘Overall Logistics & Supply Chain Management Supplier of the Year’ and also received the ‘Best Logistics & Supply Chain...
Drug Research
Hovione and GEA Strengthen Partnership to Advance Continuous Tableting Technology
Hovione, the specialist integrated CDMO and leader in spray drying and particle engineering, and GEA, a global leader in process technology for the pharmaceutical industry announced the next stage of their partnership, with new development agreements, the launch of...
Drug Research
ReciBioPharm and GeneVentiv Therapeutics partner to advance first AAV-based gene therapy for haemophilia patients with inhibitors
ReciBioPharm, the advanced and emerging therapies business unit of Recipharm, has announced a collaboration agreement with GeneVentiv Therapeutics, a pre-clinical gene therapy company, to advance development of an Adeno-Associated Virus (AAV)-based universal gene therapy for haemophilia, and the first...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read